Coating technology in the application of cardiopulmonary bypass device and its significance.docVIP

Coating technology in the application of cardiopulmonary bypass device and its significance.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Coating technology in the application of cardiopulmonary bypass device and its significance

 PAGE \* MERGEFORMAT 10 Coating technology in the application of cardiopulmonary bypass device and its significance [Keywords:] coating technology; cardiopulmonary bypass; artificial material 1963, Gott et al [1] for the first time made of heparin-coated, its anticoagulant properties be recognized. Heparin coating of the invention initially is to improve the cardiopulmonary bypass (cardiopulmonary bypass, CPB) caused by blood clotting response, but with the progress of the study, it was discovered that heparin coating also can inhibit the activation of blood components to reduce the release of inflammatory factors such as characteristics of can significantly alleviate the inflammatory response after CPB [2-5], coating technology, thus the reduction of the inflammatory response after cardiac surgery, a hot spot. Currently on the market has a variety of heparin-coated products, their composition and principles are different. At the same time, various non-heparin-coated and other coating technologies are also actively developing or have been put into clinical use, their performance compared with the heparin-coated each has its advantages. A heparin coating technology 1.1 Duraflo Ⅱ coating (Baxter Inc.) Main components of heparin - Bian Amantadine - chloride complexes, the Department of ionic bonding methods. Duraflo Ⅱ coating can reduce fibrinogen adsorption, and then to prevent platelet activation, adhesion and removal; and anti-thrombin Ⅲ interaction, preventing Ⅻ a factor and kallikrein start blood contact reaction, inhibit blood coagulation, fibrinolysis and the complement system activation and ultimately ease the body’s inflammatory response; in CPB, blood contact with the loop to form a stable double-decker biocompatible surface structure similar to human endothelial surface. 1.2 Carmeda Bioactive Surface-coated (CBAS) (Medtronic Inc.) Major components of the heparin molecules and hydrophilic substrate layer, the Department of ‘end-point attachment

文档评论(0)

hhuiws1482 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:5024214302000003

1亿VIP精品文档

相关文档